Medical News http://www.drugsfreelist.com/medical_media_news Medical News Enghlish U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) http://www.drugsfreelist.com/medical_media_news/6384/U_S__Food_And_Drug_Administration_Approves_Pfizer’s_INLYTA__axitinib__For_Patients_With_Previously_Treated_Advanced_Renal_Cell_Carcinoma__RCC_ Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia http://www.drugsfreelist.com/medical_media_news/6383/Pfizer_Announces_FDA_Acceptance_Of_New_Drug_Application_For_Bosutinib_For_Patients_With_Previously_Treated_Ph_Chronic_Myeloid_Leukemia FDA approves Inlyta to treat patients with a type of advanced kidney cancer http://www.drugsfreelist.com/medical_media_news/6382/_FDA_approves_Inlyta_to_treat_patients_with_a_type_of_advanced_kidney_cancer FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab) http://www.drugsfreelist.com/medical_media_news/6381/FDA_Drug_Safety_Communication:_New_risk_factor_for_Progressive_Multifocal_Leukoencephalopathy__PML__associated_with_Tysabri__natalizumab_ FDA. New and Generic Drug Approvals - January 27, 2012 http://www.drugsfreelist.com/medical_media_news/6380/FDA__New_and_Generic_Drug_Approvals_-_January_27,_2012 FDA. New and Generic Drug Approvals - January 26, 2012 http://www.drugsfreelist.com/medical_media_news/6379/FDA__New_and_Generic_Drug_Approvals_-_January_26,_2012 FDA. New and Generic Drug Approvals - January 25, 2012 http://www.drugsfreelist.com/medical_media_news/6378/FDA__New_and_Generic_Drug_Approvals_-_January_25,_2012 FDA. New and Generic Drug Approvals - January 24, 2012 http://www.drugsfreelist.com/medical_media_news/6377/FDA__New_and_Generic_Drug_Approvals_-_January_24,_2012 FDA. New and Generic Drug Approvals - January 23, 2012 http://www.drugsfreelist.com/medical_media_news/6376/FDA__New_and_Generic_Drug_Approvals_-_January_23,_2012 FDA. New and Generic Drug Approvals - January 20, 2012 http://www.drugsfreelist.com/medical_media_news/6375/FDA__New_and_Generic_Drug_Approvals_-_January_20,_2012 FDA. New and Generic Drug Approvals - January 19, 2012 http://www.drugsfreelist.com/medical_media_news/6374/FDA__New_and_Generic_Drug_Approvals_-_January_19,_2012 FDA. New and Generic Drug Approvals - January 18, 2012 http://www.drugsfreelist.com/medical_media_news/6373/FDA__New_and_Generic_Drug_Approvals_-_January_18,_2012 FDA expands use of endovascular graft to treat aortic tears http://www.drugsfreelist.com/medical_media_news/6372/FDA_expands_use_of_endovascular_graft_to_treat_aortic_tears FDA approves Voraxaze to treat patients with toxic methotrexate levels http://www.drugsfreelist.com/medical_media_news/6371/FDA_approves_Voraxaze_to_treat_patients_with_toxic_methotrexate_levels_ FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin) http://www.drugsfreelist.com/medical_media_news/6370/FDA_Drug_Safety_Communication:_New_Boxed_Warning_and_Contraindication_for_Adcetris__brentuximab_vedotin_ FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82 http://www.drugsfreelist.com/medical_media_news/6369/FDA_Drug_Safety_Communication:_Update:_Preliminary_findings_from_ongoing_investigations_of_CardioGen-82 FDA. New and Generic Drug Approvals - January 12, 2012 http://www.drugsfreelist.com/medical_media_news/6368/FDA__New_and_Generic_Drug_Approvals_-_January_12,_2012 FDA. New and Generic Drug Approvals - January 17, 2012 http://www.drugsfreelist.com/medical_media_news/6367/FDA__New_and_Generic_Drug_Approvals_-_January_17,_2012 FDA. New and Generic Drug Approvals - January 13, 2012 http://www.drugsfreelist.com/medical_media_news/6366/FDA__New_and_Generic_Drug_Approvals_-_January_13,_2012 FDA Approves Merck’s ISENTRESS (raltegravir) for Use in Children Ages Two Years and Older as Part of HIV-1 Combination Therapy http://www.drugsfreelist.com/medical_media_news/6365/FDA_Approves_Merck’s_ISENTRESS__raltegravir__for_Use_in_Children_Ages_Two_Years_and_Older_as_Part_of_HIV-1_Combination_Therapy GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily Relovair in COPD and asthma http://www.drugsfreelist.com/medical_media_news/6364/GSK_and_Theravance_announce_initial_outcomes_from_pivotal_Phase_III_studies_for_once-daily_Relovair__in_COPD_and_asthma Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy http://www.drugsfreelist.com/medical_media_news/6363/Biogen_Idec_and_Isis_Pharmaceuticals_Announce_Global_Collaboration_for_Antisense_Program_Targeting_Spinal_Muscular_Atrophy Shire Acquires US Rights to Resolor http://www.drugsfreelist.com/medical_media_news/6362/Shire_Acquires_US_Rights_to_Resolor Shire’s VENVANSE® (lisdexamfetamine dimesylate) Marketing Application accepted for review in Europe http://www.drugsfreelist.com/medical_media_news/6361/Shire’s_VENVANSE®__lisdexamfetamine_dimesylate__Marketing_Application_accepted_for_review_in_Europe Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met XR Tablets http://www.drugsfreelist.com/medical_media_news/6360/Mylan_Confirms_First-to-File_Patent_Challenge_Relating_to_Actoplus_Met_XR_Tablets Mylan Launches First Generic Version of Teveten Tablets http://www.drugsfreelist.com/medical_media_news/6359/Mylan_Launches_First_Generic_Version_of_Teveten_Tablets FDA to protect important class of antimicrobial drugs for treating human illness http://www.drugsfreelist.com/medical_media_news/6358/FDA_to_protect_important_class_of_antimicrobial_drugs_for_treating_human_illness Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis http://www.drugsfreelist.com/medical_media_news/6357/Genzyme_Reports_Top-line_Results_for_TENERE_Study_of_Oral_Teriflunomide_in_Relapsing_Multiple_Sclerosis Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus Spinal Cord Stimulator System http://www.drugsfreelist.com/medical_media_news/6356/Boston_Scientific_Receives_FDA_Approval_for_New_Infinion™_16_Percutaneous_Lead_for_Precision_Plus_Spinal_Cord_Stimulator_System FDA Approves Baxter`s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children with Hemophilia A http://www.drugsfreelist.com/medical_media_news/6355/FDA_Approves_Baxter`s_ADVATE_as_the_Only_FVIII_for_Routine_Prophylaxis_in_Both_Adults_and_Children_with_Hemophilia_A FDA approves mechanical cardiac assist device for children with heart failure http://www.drugsfreelist.com/medical_media_news/6354/FDA_approves_mechanical_cardiac_assist_device_for_children_with_heart_failure FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies http://www.drugsfreelist.com/medical_media_news/6353/FDA_Drug_Safety_Communication:_Selective_serotonin_reuptake_inhibitor__SSRI__antidepressant_use_during_pregnancy_and_reports_of_a_rare_heart_and_lung_condition_in_newborn_babies FDA. New and Generic Drug Approvals - December 20, 2011 http://www.drugsfreelist.com/medical_media_news/6352/FDA__New_and_Generic_Drug_Approvals_-_December_20,_2011 FDA. New and Generic Drug Approvals - December 16, 2011 http://www.drugsfreelist.com/medical_media_news/6351/FDA__New_and_Generic_Drug_Approvals_-_December_16,_2011 FDA. New and Generic Drug Approvals - December 15, 2011 http://www.drugsfreelist.com/medical_media_news/6350/FDA__New_and_Generic_Drug_Approvals_-_December_15,_2011 FDA. New and Generic Drug Approvals - December 14, 2011 http://www.drugsfreelist.com/medical_media_news/6349/FDA__New_and_Generic_Drug_Approvals_-_December_14,_2011 FDA permits marketing of the first hand-held device to aid in the detection of bleeding in the skull http://www.drugsfreelist.com/medical_media_news/6348/FDA_permits_marketing_of_the_first_hand-held_device_to_aid_in_the_detection_of_bleeding_in_the_skull U.S. Marshals seize products containing banned ephedrine for dietary supplements http://www.drugsfreelist.com/medical_media_news/6347/U_S__Marshals_seize_products_containing_banned_ephedrine_for_dietary_supplements_ FDA, FTC act to remove “homeopathic” HCG weight loss products from the market http://www.drugsfreelist.com/medical_media_news/6346/FDA,_FTC_act_to_remove_“homeopathic”_HCG_weight_loss_products_from_the_market FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults http://www.drugsfreelist.com/medical_media_news/6345/FDA_Drug_Safety_Communication:_Safety_Review_Update_of_Medications_used_to_treat_Attention-Deficit_Hyperactivity_Disorder__ADHD__in_adults FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate) http://www.drugsfreelist.com/medical_media_news/6344/FDA_Drug_Safety_Communication:_Safety_review_of_post-market_reports_of_serious_bleeding_events_with_the_anticoagulant_Pradaxa__dabigatran_etexilate_mesylate_ FDA Drug Safety Communication: Modified Risk Evaluation and Mitigation Strategies (REMS) for Nplate (romiplostim) and Promacta (eltrombopag) http://www.drugsfreelist.com/medical_media_news/6343/FDA_Drug_Safety_Communication:_Modified_Risk_Evaluation_and_Mitigation_Strategies__REMS__for_Nplate__romiplostim__and_Promacta__eltrombopag_ FDA. New and Generic Drug Approvals - December 13, 2011 http://www.drugsfreelist.com/medical_media_news/6342/FDA__New_and_Generic_Drug_Approvals_-_December_13,_2011 FDA. New and Generic Drug Approvals - December 12, 2011 http://www.drugsfreelist.com/medical_media_news/6341/FDA__New_and_Generic_Drug_Approvals_-_December_12,_2011 FDA. New and Generic Drug Approvals - December 9, 2011 http://www.drugsfreelist.com/medical_media_news/6340/FDA__New_and_Generic_Drug_Approvals_-_December_9,_2011 FDA. New and Generic Drug Approvals - December 8, 2011 http://www.drugsfreelist.com/medical_media_news/6339/FDA__New_and_Generic_Drug_Approvals_-_December_8,_2011 FDA. New and Generic Drug Approvals - December 7, 2011 http://www.drugsfreelist.com/medical_media_news/6338/FDA__New_and_Generic_Drug_Approvals_-_December_7,_2011 FDA. New and Generic Drug Approvals - December 6, 2011 http://www.drugsfreelist.com/medical_media_news/6337/FDA__New_and_Generic_Drug_Approvals_-_December_6,_2011 Roche`s cobas EGFR Mutation Test For Personalized Treatment Of Non-Small Cell Lung Cancer Receives CE Mark http://www.drugsfreelist.com/medical_media_news/6336/Roche`s_cobas_EGFR_Mutation_Test_For_Personalized_Treatment_Of_Non-Small_Cell_Lung_Cancer_Receives_CE_Mark Long-term use of antiepileptic drug Vimpat® (lacosamide) reduced seizure frequency and severity and improved health-related quality of life measures http://www.drugsfreelist.com/medical_media_news/6335/Long-term_use_of_antiepileptic_drug_Vimpat®__lacosamide__reduced_seizure_frequency_and_severity_and_improved_health-related_quality_of_life_measures